T2D

Research ID	Investigator Name	Research Topic	Research Status
1	Panu	Disease Progression of Type 2 Diabetes Mellitus: A cohort profile	For graduation
2	Panu	Retinopathy prediction in type 2 diabetes: time-varying Cox proportional hazards and machine learning models	Published
3	Teerapat	Treatment effectiveness of second-line drugs in prevention of HF	For graduation
4	Teerapat	Prognostic factors of HF in T2D	MS submitted
5	Sukanya	Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes	Published
6	Thitiya	Effect of second-line drugs on diabetic ratinopathy	On going
7	Thunyarat	Effect of second-line drugs on fatty liver (NAFLD/NASH)	On going
8	Nathorn	GLP1 and BMI	On going
9	Montarat	Cost-Utility Analysis of Laparoscopic Bariatric Surgery for Obesity with type II Diabetes Mellitus	For graduation
12	Thunyarat	Short and Long term outcomes between patients who are treated in DM clinic vs non-DM clinic	For graduation
13	Ammarin	Association of statin therapy initiation with diabetes progression (TE+mediation)	Approved
14	Ammarin	T2D real-world medications use	Drafting MS
15	Thitiya	Cucurmin supplement and glycemic control	On going
30	Oraluck	Cost-Effectiveness of Second-line Drugs for Improved Glycaemic Control for Type 2 Diabetes Mellitus in Thailand	On going
31	Sukanya	GLP1-RA and BW, BMI with difference in difference	Drafting MS
32	Rou Teh	predictive ability of visit-to-visit glucose variability on diabetes complications	Drafting MS
35	Ammarin	Effects of curcumin supplementation on glucose metabolism in diabetes mellitus and metabolic syndrome: an umbrella review and updated meta-analysis	Published
36	Amarit	Effects of second-line antihyperglycemic medications on chronic kidney disease progression: A multistate analysis	Drafting MS
43	Panu	Treatment effectiveness of VEGF and laser on ocular and systemic outcomes in diabetic retinopathy	On going
44	Hataikarn	Effect of second-line drugs on osteoporosis and/or fractures	On going
45	Sukanya	Clinical effect of SGLT2i on CKD, CVD; Mediation analysis	Approved
46	Sukanya	Individual treatment effects of sodium-glucose cotransporter-2 inhibitors on the risk of chronic kidney disease using ML	On going
47	Tanawan	CUA and BIA of adding SGLT2 inhibitors to standard treatment in T2D with CHF	Drafting MS
48	Sukanya	Counterfactual prognostic model under hypothetical treatment of SGLT2i in CKD lowering risk in type 2 diabetes	MS submitted
49	Romen	Multiple Imputation by Chained Equations using Conventional and Machine Learning Models accounting for Uncertainty	On going
52	Thitiya	Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial	Published
53	Panu	A multistate models of T2D progression: Conventional statistical and machine learning models	On going
58	Thunyarat	Effect of second-line drugs on metabolic dysfunction-associated fatty liver disease (MAFLD)	Approved
61	Amarit	SGLT2i and chronic kidney disease progression in T2D	MS submitted
64	Amarit	SGLT2i effect on AKI patients: A multistate analysis from multicenter data	On going
66	Amarit	Monotherapy va combined anti-diabetic drugs in T2D	On going